通常身體檢查,膽固醇測試少不了,但那個簡單的測試,基本上意義不大,低膽固醇人,或正常的膽固醇,都不代表你沒有患是中風,心臟病的機會。高膽固醇,也不代表你有風險。
因爲沒有測試到真正導致問題的源頭數據。心血管疾病測試的三個少有人知主要數據。
關鍵是你的胰島素阻抗和發炎因:子有多高,
今天,我來分享我的學習和如何改善減少患心血管疾病的風險:
( 請留意最後的個案分享,我的文章)
最準確的測試,是要拿出這三個數據:
Heart disease test with the three most important facotors:
3 LAB TESTS you should know that aren't on a Standard Panel
1) Apolipoprotein B -
载脂蛋白B(ApoB)
2) LIPOPROTEI a <lp(a)> -
脂蛋白(a) 遺傳性
3) High sensitivity C - Reactive Protein ( Hs- CRP) - elevated CRP
C反应蛋白
1) Apolipoprotein B- 肝發炎狀況
A
https://youtube.com/shorts/9U12X4g7Yv4?si=MBThLfFcYbjO_UI5
It is about Cholesterol LDL with high oxidized bricks and other bricks or taxis , particles. With a normal LDL or high LDL does not mean you have heart disease or disease risk.
This is an excellent and important question.
For decades, the standard test has been **LDL-C (LDL Cholesterol)**, which measures the *amount of cholesterol* inside LDL particles. However, research over the past 20+ years has shown that the **number of particles** is a more accurate predictor of cardiovascular risk.
What is the dangerous particles:
Here’s the key insight: **You can have a "normal" LDL-C level but a high number of small, dense LDL particles.** These particles are especially dangerous because they can easily slip into the artery wall and contribute to inflamation and plaque formation.
Here is a comprehensive overview of Apolipoprotein B (ApoB), explaining what it is, why it's crucial, and how it differs from other cholesterol tests.
什么是载脂蛋白B(ApoB)?
简单来说,ApoB是存在于最具致动脉粥样硬化性(导致动脉堵塞)的脂蛋白表面的主要结构蛋白。
可以这样理解:脂蛋白就像出租车,在血液中运输胆固醇和甘油三酯。而ApoB就是那些最可能导致斑块形成的“出租车司机”。
以下每一种有害颗粒的表面都带有一个ApoB分子:
乳糜微粒: 从小肠运输膳食脂肪。
极低密度脂蛋白(VLDL): 运输肝脏产生的甘油三酯。
中密度脂蛋白(IDL): 是VLDL向LDL转化的中间颗粒。
低密度脂蛋白(LDL): 即臭名昭著的“坏胆固醇”,是胆固醇的主要载体。
脂蛋白(a) [Lp(a)]: 一种尤其危险、受遗传影响的LDL类型。
因此,检测ApoB可以直接计数血液中这些致动脉粥样硬化颗粒的总数。
为什么ApoB如此重要?“颗粒数量”理论
几十年来,标准检测一直是LDL-C(低密度脂蛋白胆固醇),它测量的是LDL颗粒内部的胆固醇含量。然而,过去20多年的研究表明,颗粒数量是预测心血管风险更准确的指标。
关键点在于:你的LDL-C水平可能“正常”,但小而密的LDL颗粒数量却可能很高。 这些颗粒尤其危险,因为它们更容易进入动脉壁,促进斑块形成。是因爲被氧化,發炎后產生的高密度快狀,可以刺破血管。
LDL-C(胆固醇含量) 就像测量一队出租车里乘客的总重量。
ApoB(颗粒数量) 就像精确计算路上行驶的出租车数量。
ApoB计数高意味着你的动脉中有大量“出租车”(颗粒)在穿梭,增加了“车辆”撞击并损伤动脉壁、启动动脉粥样硬化过程的风险。
ApoB 与其他血脂标志物的比较
标志物 | 测量内容 | 用途 | 局限性 |
---|---|---|---|
LDL-C | LDL颗粒内部的胆固醇质量。 | 传统的、广泛使用的“坏胆固醇”标准。 | 未考虑颗粒的数量或大小,可能漏检高风险。 |
非HDL-C | 总胆固醇减去HDL胆固醇。(包含VLDL、IDL、LDL)。 | 比LDL-C更好的标志物;包含所有致动脉粥样硬化胆固醇。 | 仍是胆固醇含量的测量,而非颗粒计数。 |
ApoB | 所有致动脉粥样硬化颗粒(VLDL、IDL、LDL、Lp(a))的数量。 | 被认为是评估血脂相关心血管风险的单一最佳标志物。 | 不如传统血脂组套应用广泛或常被开具(但正在改变)。 |
总结:在评估致动脉粥样硬化脂蛋白带来的风险方面,ApoB是比LDL-C更直接、更准确的指标。
何时建议进行ApoB检测?
ApoB检测在以下情况中特别有用:
个人或家族心脏病史: 尤其是在年轻时发病的情况。
高甘油三酯血症 / 代谢综合征: 患有这些疾病的人通常拥有大量小而密的LDL颗粒,而标准LDL-C检测可能会低估其风险。
糖尿病: 糖尿病显著增加心血管风险,ApoB有助于细化风险评估。
细化风险评估: 当传统血脂组套结果处于临界值或相互矛盾时。
监测治疗效果: 观察降胆固醇药物(如他汀类药物)是否能有效减少有害颗粒的数量。
检测结果意味着什么?(ApoB水平)
目标水平可能因实验室和指南略有不同,但总体框架如下:
低风险: < 80 mg/dL(或 < 0.80 g/L)
中/高风险(或正在接受治疗): < 65 mg/dL(或 < 0.65 g/L)是一个常见的积极控制目标。
极高风险(例如,已患有心脏病): 目标可能为 < 55 mg/dL(或 < 0.55 g/L)。
ApoB水平高表明心脏病发作、中风和外周动脉疾病的风险增加。
如何降低ApoB
方法与降低LDL-C的策略相同,因为它们针对的是相同的颗粒:
饮食:
减少饱和脂肪摄入(红肉、全脂乳制品、黄油)。
避免反式脂肪(加工食品、油炸食品)。
增加可溶性纤维摄入(燕麦、大麦、豆类、苹果)。
运动: 规律的有氧运动。
体重管理: 减掉多余体重。
药物: 他汀类药物是一线疗法。其他选择包括依折麦布、PCSK9抑制剂和胆汁酸螯合剂。
核心要点
载脂蛋白B(ApoB)被许多专家认为是评估血脂所致动脉粥样硬化风险的单一最佳血液检测指标。 它直接计数所有有害的胆固醇携带颗粒,比传统的“低密度脂蛋白胆固醇”检测能提供更精确的风险情况。如果您担心自己的心脏病风险,与医生讨论进行ApoB检测是一个非常积极的步骤。
What is Apolipoprotein B (ApoB)?
In simple terms, ApoB is the main structural protein found on the surface of the most atherogenic (artery-clogging) lipoproteins.
Think of it this way: Lipoproteins are like taxis that carry cholesterol and triglycerides through your bloodstream. ApoB is the driver of the taxis that are most likely to cause plaque buildup.
Every single one of the following harmful particles has one ApoB molecule on its surface:
Chylomicrons: Carry dietary fat from the intestine.
VLDL (Very-Low-Density Lipoprotein): Carries triglycerides made by the liver.
IDL (Intermediate-Density Lipoprotein): A transition particle between VLDL and LDL.
LDL (Low-Density Lipoprotein): The infamous "bad cholesterol." This is the primary carrier of cholesterol.
Lp(a): A particularly dangerous, genetically influenced type of LDL.
Therefore, measuring ApoB gives you a direct count of the total number of these atherogenic particles in your blood.
Why is ApoB So Important? The "Particle Number" Theory
For decades, the standard test has been LDL-C (LDL Cholesterol), which measures the amount of cholesterol inside LDL particles. However, research over the past 20+ years has shown that the number of particles is a more accurate predictor of cardiovascular risk.
Here’s the key insight: You can have a "normal" LDL-C level but a high number of small, dense LDL particles. These particles are especially dangerous because they can easily slip into the artery wall and contribute to plaque.
LDL-C (Cholesterol Content) is like measuring the total weight of passengers in a fleet of taxis.
ApoB (Particle Number) is like counting the exact number of taxis on the road.
A high ApoB count means you have a lot of "taxis" (particles) roaming your arteries, increasing the chance of one crashing into and damaging the arterial wall, starting the process of atherosclerosis.
ApoB vs. Other Lipid Markers
Marker | What It Measures | Why It's Used | Limitation |
---|---|---|---|
LDL-C | The cholesterol mass inside LDL particles. | The traditional, widely available standard for "bad cholesterol." | Doesn't account for the number or size of particles. Can miss high risk. |
Non-HDL-C | Total cholesterol minus HDL cholesterol. (Includes VLDL, IDL, LDL). | A better marker than LDL-C; includes all atherogenic cholesterol. | Still a measure of cholesterol content, not particle count. |
ApoB | The number of all atherogenic particles (VLDL, IDL, LDL, Lp(a)). | Considered the best single marker for cardiovascular risk related to lipids. | Not as widely available or ordered as traditional panels (though this is changing). |
In summary: ApoB is a more direct and accurate measure of your risk from atherogenic lipoproteins than LDL-C.
When is an ApoB Test Recommended?
An ApoB test is particularly useful in these scenarios:
Personal or Family History of Heart Disease: Especially if it occurred at a young age.
High Triglycerides / Metabolic Syndrome: People with these conditions often have a high number of small, dense LDL particles, which a standard LDL-C test can underestimate.
Diabetes: Diabetes significantly increases cardiovascular risk, and ApoB helps refine that risk assessment.
To Refine Risk Assessment: When traditional lipid panel results are borderline or conflicting.
Monitoring Treatment: To see if cholesterol-lowering drugs (like statins) are effectively reducing the number of harmful particles.
What Do the Results Mean? (ApoB Levels)
Target levels can vary slightly by lab and guidelines, but a general framework is:
Low Risk: < 80 mg/dL (or < 0.80 g/L)
Moderate/High Risk (or on treatment): < 65 mg/dL (or < 0.65 g/L) is a common aggressive target.
Very High Risk (e.g., existing heart disease): < 55 mg/dL (or < 0.55 g/L) may be the goal.
A high ApoB level indicates an increased risk for heart attack, stroke, and peripheral artery disease.
How to Lower ApoB
The strategies are the same as for lowering LDL-C, as they target the same particles:
Diet:
Reduce saturated fats (red meat, full-fat dairy, butter).
Eliminate trans fats (processed foods, fried foods).
Increase soluble fiber (oats, barley, beans, apples).
Exercise: Regular aerobic activity.
Weight Management: Losing excess weight.
Medications: Statins are the first-line therapy. Other options include Ezetimibe, PCSK9 inhibitors, and bile acid sequestrants.
Key Takeaway
Apolipoprotein B (ApoB) is considered by many experts to be the single best blood test for assessing the risk of atherosclerosis caused by lipids. It provides a direct count of all the dangerous cholesterol-carrying particles, offering a more precise risk picture than the traditional "LDL Cholesterol" test. If you are concerned about your heart disease risk, discussing an ApoB test with your doctor is a very proactive step.
2) LIPOPROTEI a <lp(a)>
It increase the speed of inflammation and clog formation. It is sticky , highly inflammation particles.
DEEPSEEK
什么是脂蛋白(a)?
脂蛋白(a),通常写作 Lp(a),是一种由蛋白质和脂肪组成的颗粒,负责在血液中运输胆固醇。您可以把它理解为低密度脂蛋白(LDL,即“坏”胆固醇)的一种特殊亚型,但其结构独特,潜在危害性更大。
理解 Lp(a) 的关键在于其独特的结构:
类似LDL的颗粒: 它的核心部分与LDL颗粒非常相似,包含一个富含胆固醇的中心。
载脂蛋白(a): 这是最关键的区别。在这个LDL样颗粒上,附着了一种独特的蛋白质,称为 载脂蛋白(a),即 Apo(a)。这种蛋白质的结构与纤溶酶原非常相似,而纤溶酶原是人体凝血系统中一种关键的蛋白质。
这种双重特性——既参与胆固醇运输,又干扰凝血系统——使得 Lp(a) 尤其有害。
为什么 Lp(a) 如此重要?其风险是什么?
目前,高水平的 Lp(a) 被公认为是一个主要的、独立的、遗传性的、致病性的风险因素,会导致:
动脉粥样硬化性心血管疾病(ASCVD): 即动脉中斑块的积聚,导致:
心脏病发作(心肌梗死)
中风(缺血性)
外周动脉疾病
主动脉瓣狭窄: 心脏主动脉瓣的狭窄和钙化。Lp(a) 与这种疾病的关联性特别强。
它为何如此危险?
促动脉粥样硬化: 像LDL一样,Lp(a) 颗粒可以进入动脉壁,被氧化,并驱动斑块形成。
促血栓形成: 由于其 Apo(a) 蛋白与纤溶酶原相似,它会干扰身体分解血凝块的能力,从而增加形成危险血栓的风险。
Lp(a) 的主要特性
由基因决定: 您的 Lp(a) 水平几乎完全(超过90%)由基因决定。它不会受到饮食、运动或大多数生活方式改变的显著影响。如果您 Lp(a) 水平高,很可能是天生的。
非常规筛查项目: 它不包含在标准的血脂检测中。您必须将其作为一项单独的检测来申请。
“沉默”的风险因素: 您可能 Lp(a) 水平很高,但感觉完全健康,没有任何症状,直到心血管事件发生。
哪些人应该检测 Lp(a)?
医学指南建议以下人群进行检测:
有早发性心血管疾病个人史(例如,男性<55岁,女性<65岁发生心脏病或中风)。
有早发性心脏病或高 Lp(a) 家族史。
在没有其他明确风险因素的情况下,有强大的心血管疾病家族史。
个人或家族有主动脉瓣狭窄史。
即使接受治疗,LDL胆固醇仍然很高(为了评估整体风险)。
用于优化风险评估: 即使没有强大的家族史,了解您的 Lp(a) 水平也有助于您和医生了解您真实的心血管风险。
如何解读检测结果
Lp(a) 以 mg/dL(毫克/分升)或 nmol/L(纳摩尔/升)为单位测量。nmol/L 被认为更准确。
理想 / 低风险: < 30 mg/dL 或 < 75 nmol/L
高风险: > 50 mg/dL 或 > 125 nmol/L
极高风险: > 100 mg/dL 或 > 250 nmol/L
如果您的水平很高,意味着您拥有一个遗传性的、终生升高的心脏病和中风风险。
治疗:现状与未来
这是最关键的部分。目前,还没有任何已获批的、能够证明可以降低心血管事件的特异性降低 Lp(a) 的药物。
他汀类药物(如阿托伐他汀、瑞舒伐他汀): 这些药物在降低LDL胆固醇方面非常有效,但不能降低 Lp(a)。事实上,它们可能会轻微升高 Lp(a)。但是,如果您同时有高 Lp(a) 和高 LDL,治疗高 LDL 仍然是绝对必要的。
烟酸(Niacin): 可以降低 Lp(a) 约 20-30%,但其副作用很常见(潮红、瘙痒),且临床试验未显示其在减少心脏病发作方面有明确益处。
PCSK9 抑制剂(如依洛尤单抗、阿利西尤单抗): 这些强效的降LDL注射药物也能降低 Lp(a) 约 20-30%。
未来充满希望:Lp(a) 特异性疗法
目前有几种药物处于高级临床试验阶段,它们通过靶向 Lp(a) 的生成过程,能够直接且显著地降低其水平。最有前景的是:
Pelacarsen (TQJ230): 一种“反义寡核苷酸”,通过皮下注射给药。
Olpasiran (AMG 890): 一种“小干扰RNA”,通过注射给药。
这些药物在试验中已显示出能够降低 80-95% 的 Lp(a) 水平。关键的结果试验正在进行中,以验证这种降低是否能转化为更少的心脏病发作和中风。
如果您的 Lp(a) 水平偏高,该怎么办?
不要恐慌。 知识就是力量。您已经确定了一个可以主动管理的关键风险因素。
咨询专家。 去看心脏科医生或血脂专家。
积极管理所有其他风险因素。 这是当前的标准治疗方案。既然目前还不能直接降低 Lp(a),您必须一丝不苟地管理其他因素:
LDL胆固醇: 尽可能将其降至最低。
血压: 严格控制。
血糖: 预防或管理糖尿病。
生活方式: 绝对戒烟,保持心脏健康的饮食,定期运动,保持健康体重。
考虑阿司匹林: 与您的医生讨论低剂量阿司匹林是否适合您,以帮助降低血栓风险。
家族筛查: 告知您的血亲(父母、兄弟姐妹、子女),以便他们也能进行检测。
总结
特征 | 描述 |
---|---|
是什么 | 血液中一种独特的、类似LDL的颗粒,带有一个附加的“粘性”蛋白(Apo(a))。 |
主要风险 | 是心脏病、中风和主动脉瓣狭窄的独立、遗传性风险因素。 |
关键事实 | 水平由基因决定,不受生活方式影响。 |
检测 | 非例行检测;建议有个人/家族早发心脏病史者进行。 |
当前治疗 | 尚无获批的特效降Lp(a)药物。重点是积极管理所有其他风险因素。 |
未来治疗 | 处于临床试验阶段的药物前景广阔,可降低 Lp(a) 达 80% 以上。 |
What is Lp(a)?
Lp(a) is a type of lipoprotein, a particle made of protein and fat that carries cholesterol through the bloodstream. Think of it as a subtype of LDL ("bad") cholesterol, but with a unique and potentially more dangerous structure.
The key to understanding Lp(a) is its unique structure:
LDL-like particle: At its core, it looks very similar to an LDL particle, containing a cholesterol-rich center.
Apo(a) protein: This is the critical difference. Attached to the LDL-like particle is a unique protein called Apolipoprotein(a), or Apo(a). This protein has a structure that is very similar to plasminogen, a key protein in the body's blood-clotting (thrombolytic) system.
This dual nature—mixing cholesterol transport with interference in clotting—is what makes Lp(a) particularly harmful.
Why is Lp(a) Important? The Risks
High levels of Lp(a) are now recognized as a major independent, genetic, and causal risk factor for:
Atherosclerotic Cardiovascular Disease (ASCVD): The buildup of plaque in arteries, leading to:
Heart attacks (Myocardial Infarction)
Strokes (Ischemic)
Peripheral arterial disease
Aortic Stenosis: A narrowing and calcification of the aortic valve in the heart. This is a particularly strong association.
Why is it so dangerous?
Pro-Atherogenic: Like LDL, the Lp(a) particle can enter the artery wall, become oxidized, and drive plaque formation.
Pro-Thrombotic: Because its Apo(a) protein resembles plasminogen, it interferes with the body's ability to break down blood clots. This increases the risk of dangerous clot formation.
Key Characteristics of Lp(a)
Genetically Determined: Your Lp(a) level is almost entirely (over 90%) determined by your genes. It is not significantly influenced by diet, exercise, or most lifestyle changes. If you have high Lp(a), you were likely born with it.
Not Routinely Screened: It is not part of a standard lipid panel (which measures Total Cholesterol, LDL, HDL, and Triglycerides). You must request it as a separate test.
"Silent" Risk: You can have high Lp(a) and feel perfectly healthy, with no symptoms, until a cardiovascular event occurs.
Who Should Get Tested for Lp(a)?
Medical guidelines recommend testing in the following situations:
Personal history of premature cardiovascular disease (e.g., heart attack or stroke at a young age: <55 for men, <65 for women).
Family history of premature heart disease or high Lp(a).
A strong family history of cardiovascular disease without other clear risk factors (like high LDL, diabetes, or smoking).
Personal or family history of aortic stenosis.
Having high LDL cholesterol despite treatment (to assess overall risk).
To refine risk assessment: Even without a strong family history, knowing your Lp(a) level can help you and your doctor understand your true cardiovascular risk.
Interpretation of Results
Lp(a) is measured in mg/dL (milligrams per deciliter) or nmol/L (nanomoles per liter). nmol/L is considered more accurate.
Desirable / Low Risk: < 30 mg/dL or < 75 nmol/L
High Risk: > 50 mg/dL or > 125 nmol/L
Very High Risk: > 100 mg/dL or > 250 nmol/L
If your level is high, it means you have a genetically inherited, lifelong elevated risk for heart disease and stroke.
Treatment: The Current and Future Landscape
This is the most critical part. There are currently no approved medications specifically for lowering Lp(a) that have been proven to reduce cardiovascular events.
Statins (e.g., Atorvastatin, Rosuvastatin): These are very effective at lowering LDL cholesterol but do not lower Lp(a). In fact, they may slightly increase it. However, if you have high Lp(a) and high LDL, treating the high LDL is still absolutely essential.
Niacin: Can lower Lp(a) by 20-30%, but its side effects are common (flushing, itching), and clinical trials have not shown a clear benefit for reducing heart attacks.
PCSK9 Inhibitors (e.g., Evolocumab, Alirocumab): These powerful LDL-lowering injectable drugs can also lower Lp(a) by about 20-30%.
Estrogen and Aspirin: May have modest lowering effects but are not used as primary treatments for high Lp(a).
The Future is Bright: Lp(a)-Specific Therapies
There are several drugs in advanced clinical trials that directly and dramatically lower Lp(a) by targeting its production. The most promising are:
Pelacarsen (TQJ230): An "antisense oligonucleotide" given by subcutaneous injection.
Olpasiran (AMG 890): A "small interfering RNA" (siRNA) given by injection.
These drugs have shown an 80-95% reduction in Lp(a) levels in trials. The critical outcome trials to see if this reduction translates to fewer heart attacks and strokes are ongoing.
What to Do If Your Lp(a) is High
Don't Panic. Knowledge is power. You have identified a key risk factor that you can now manage proactively.
See a Specialist. Consult with a cardiologist or lipidologist (a cholesterol specialist).
Aggressively Manage ALL Other Risk Factors. This is the current standard of care. Since you can't directly lower Lp(a) yet, you must be meticulous with other factors:
LDL Cholesterol: Get it as low as possible.
Blood Pressure: Keep it under control.
Blood Sugar: Prevent or manage diabetes.
Lifestyle: Do not smoke, eat a heart-healthy diet, exercise regularly, and maintain a healthy weight.
Consider Aspirin: Discuss with your doctor if low-dose aspirin is appropriate for you to help reduce clotting risk.
Family Screening: Inform your blood relatives (parents, siblings, children) so they can also get tested.
Summary
Feature | Description |
---|---|
What it is | A unique, LDL-like particle in the blood with an added "sticky" protein (Apo(a)). |
Primary Risk | Independent, genetic risk factor for heart attack, stroke, and aortic stenosis. |
Key Fact | Levels are genetically determined and not affected by lifestyle. |
Testing | Not routine; recommended for those with personal/family history of early heart disease. |
Current Treatment | No approved drugs to lower it. Focus is on aggressively managing all other risk factors. |
Future Treatment | Highly promising drugs in clinical trials that can lower Lp(a) by over 80%. |
3) High sensitivity C - Reactive Protein ( Hs- CRP) - elevated CRP
To measure inflammation, the silent amplifier of clogging due to chronic stress, poor sleep, metabolic dysfunction, depression, chronic diseases that cause chronic inflammation.
首先,什么是C反应蛋白?
C反应蛋白 是一种由肝脏产生的蛋白质。它是人体炎症反应的关键参与者。当身体任何部位出现炎症时,肝脏就会向血液中释放CRP。可以把它看作一个通用的警报系统。
标准CRP检测: 测量较高浓度的CRP,用于检测严重的炎症,如由严重细菌感染、重大创伤或慢性炎症性疾病(如类风湿关节炎)引起的炎症。
高敏C反应蛋白检测: 检测的是同一种蛋白质,但灵敏度要高得多。它可以检测到血液中非常低水平的CRP,这些低水平通常与低程度的慢性炎症有关。
Hs-CRP升高意味着什么?
Hs-CRP升高表明身体处于一种低程度、全身性的炎症状态。这不是由割伤或感染引起的急性炎症,而是一种持续的、全身性的、会随时间推移损害血管的「闷烧」型炎症。
Hs-CRP升高最重要且研究最充分的含义是其与心血管疾病的关联。
1. 主要用途:心血管风险评估
您的医生要求检测Hs-CRP,很可能是作为心血管风险评估的一部分。它能提供胆固醇检测无法单独提供的信息。
理论依据: 动脉血管壁内的慢性炎症会使脂肪斑块(动脉粥样硬化)更容易形成,并且关键的是,更容易破裂。斑块破裂可能导致心脏病发作或中风。
Hs-CRP作为预测指标: Hs-CRP升高表明这种炎症过程是活跃的,它可以独立预测未来心脏病发作、中风和外周动脉疾病的风险,即使您的胆固醇水平正常。
用于心脏病风险评估的Hs-CRP标准范围:
低风险: Hs-CRP < 1.0 mg/L
中度风险: Hs-CRP 在 1.0 到 3.0 mg/L 之间
高风险: Hs-CRP > 3.0 mg/L
重要提示: 如果Hs-CRP水平高于 10.0 mg/L,则表明可能存在显著的炎症源(如活动性感染或疾病),此时该数值不再适用于心血管风险评估。应在疾病痊愈后重新检测。
2. 导致升高的其他可能原因
虽然心血管炎症是主要关注点,但Hs-CRP升高也可能由许多其他导致慢性炎症的疾病引起:
自身免疫性疾病: 类风湿关节炎、狼疮、炎症性肠病(克罗恩病、溃疡性结肠炎)。
代谢综合征: 一系列健康状况的集合,包括胰岛素抵抗、高血压和腹型肥胖。
感染: 慢性低程度感染。
肥胖: 脂肪组织,尤其是内脏脂肪,会产生炎症性化学物质。
吸烟: 是导致全身性炎症的主要原因之一。
久坐生活方式: 缺乏体育活动与较高的炎症标志物有关。
不良饮食: 高糖、高精制碳水化合物和高饱和/反式脂肪的饮食会促进炎症。
睡眠呼吸暂停: 睡眠期间间歇性的低氧会引发炎症。
牙周病: 牙龈的慢性感染会导致全身性炎症。
癌症: 某些癌症可能导致炎症标志物升高。
如果您的Hs-CRP升高,该怎么办?
Hs-CRP升高是一个警告信号,而非诊断。它呼吁您采取行动,识别并处理根本原因。
1. 与您的医生合作
医生会结合您的整体健康状况来解读这个结果。他们会:
排除近期明显的疾病或感染。
考虑进行其他检查(例如,针对自身免疫性疾病)。
评估您的整体心血管风险(胆固醇、血压、糖尿病筛查、家族史)。
2. 改变生活方式是关键
通过改变生活方式来处理根本原因,是降低Hs-CRP最有效的方法。
采取抗炎饮食:
增加: 水果、蔬菜、全谷物、坚果、种子和富含Omega-3的肥鱼(如三文鱼、鲭鱼)。
减少: 糖、含糖饮料、精制碳水化合物(白面包、面条)、加工食品和红肉。
可以考虑: 地中海饮食是一种非常优秀的抗炎饮食模式。
定期锻炼:
目标是每周至少进行150分钟的中等强度有氧运动(如快走、骑自行车)或75分钟的高强度运动。
规律运动是一种强大的抗炎手段。
达到并保持健康体重:
即使减去体重5-10%也能显著减轻炎症。
如果您吸烟,请戒烟: 这是您可以采取的最具影响力的行动之一。
管理压力: 慢性压力会提升皮质醇和其他炎症化学物质的水平。练习如冥想、深呼吸或瑜伽等技巧。
保证睡眠优先: 目标是每晚获得7-9小时的高质量睡眠。处理如睡眠呼吸暂停等睡眠障碍。
保持良好的口腔卫生: 定期使用牙线和刷牙以控制牙周病。
3. 药物干预
根据您的整体风险,您的医生可能会建议:
他汀类药物: 这些降胆固醇药物也具有强大的抗炎作用,并被证明可以降低Hs-CRP水平和心血管事件的风险。
低剂量阿司匹林: 对于某些高风险人群,可能会建议使用(务必在医生指导下)。
总结
Hs-CRP升高 = 体内存在低程度的慢性炎症。
其最关键的暗示是心脏病发作和中风的风险增加。
它是一个可改变的风险因素。通过显著的生活方式改变,并在必要时结合药物治疗,您可以降低您的Hs-CRP水平,更重要的是,可以降低您的整体健康风险。
First, What is CRP?
C-Reactive Protein (CRP) is a protein produced by your liver. It's a key player in your body's inflammatory response. When there is inflammation anywhere in your body, your liver releases CRP into the bloodstream. Think of it as a general alarm system.
Standard CRP Test: This measures much higher levels of CRP and is used to detect major inflammation, like that caused by a serious bacterial infection, a major injury, or a chronic inflammatory disease (e.g., rheumatoid arthritis).
High-Sensitivity CRP (hs-CRP) Test: This is the same protein, but the test is far more sensitive. It can detect very low levels of CRP in the bloodstream, which are often linked to low-grade, chronic inflammation.
What Does an Elevated Hs-CRP Mean?
An elevated hs-CRP indicates a state of low-grade, systemic inflammation. This is not the acute inflammation from a cut or an infection, but a smoldering, body-wide inflammation that can damage blood vessels over time.
The most significant and well-researched implication of an elevated hs-CRP is its link to cardiovascular disease.
1. Primary Use: Cardiovascular Risk Assessment
Your doctor likely ordered the hs-CRP test as part of a cardiovascular risk assessment. It provides information that cholesterol tests alone cannot.
The Theory: Chronic inflammation inside the walls of your arteries can make fatty plaques (atherosclerosis) more likely to form and, crucially, more likely to rupture. A ruptured plaque can cause a heart attack or stroke.
hs-CRP as a Predictor: Elevated hs-CRP indicates this inflammatory process is active, independently predicting your risk for future heart attacks, strokes, and peripheral arterial disease, even if your cholesterol levels are normal.
Standard hs-CRP Risk Categories for Heart Disease:
Low Risk: hs-CRP less than 1.0 mg/L
Average Risk: hs-CRP between 1.0 and 3.0 mg/L
High Risk: hs-CRP greater than 3.0 mg/L
Important Note: An hs-CRP level above 10.0 mg/L suggests a major source of inflammation (like an active infection or illness) and is not considered useful for cardiovascular risk assessment. The test should be repeated after the illness has resolved.
2. Other Potential Causes of Elevation
While cardiovascular inflammation is a primary concern, an elevated hs-CRP can be due to many other conditions that cause chronic inflammation:
Autoimmune Diseases: Rheumatoid arthritis, lupus, inflammatory bowel disease (Crohn's, ulcerative colitis).
Metabolic Syndrome: A cluster of conditions including insulin resistance, high blood pressure, and abdominal obesity.
Infections: Chronic low-grade infections.
Obesity: Fat tissue, especially visceral belly fat, produces inflammatory chemicals.
Smoking: A major cause of systemic inflammation.
Sedentary Lifestyle: Lack of physical activity is linked to higher inflammatory markers.
Poor Diet: Diets high in sugar, refined carbs, and saturated/trans fats can promote inflammation.
Sleep Apnea: Intermittent low oxygen levels during sleep can trigger inflammation.
Periodontal (Gum) Disease: Chronic infection in the gums can lead to systemic inflammation.
Cancer: Some cancers can cause elevated inflammatory markers.
What to Do If Your Hs-CRP is Elevated
An elevated hs-CRP is a warning sign, not a diagnosis. It's a call to action to identify and address the underlying cause.
1. Work With Your Doctor
Your doctor will interpret the result in the context of your overall health. They will:
Rule out an obvious recent illness or infection.
Consider other tests (e.g., for autoimmune conditions).
Assess your overall cardiovascular risk (cholesterol, blood pressure, diabetes screening, family history).
2. Lifestyle Modifications are Key
The most effective way to lower hs-CRP is by addressing the root causes through lifestyle changes.
Adopt an Anti-Inflammatory Diet:
Increase: Fruits, vegetables, whole grains, nuts, seeds, and fatty fish (like salmon and mackerel rich in Omega-3s).
Decrease: Sugar, sugary drinks, refined carbohydrates (white bread, pasta), processed foods, and red meat.
Consider: The Mediterranean diet is an excellent anti-inflammatory eating pattern.
Exercise Regularly:
Aim for at least 150 minutes of moderate-intensity aerobic exercise (like brisk walking, cycling) or 75 minutes of vigorous exercise per week.
Regular exercise is a powerful anti-inflammatory.
Achieve and Maintain a Healthy Weight:
Losing even 5-10% of your body weight can significantly reduce inflammation.
If You Smoke, Quit: This is one of the most impactful actions you can take.
Manage Stress: Chronic stress elevates cortisol and other inflammatory chemicals. Practice techniques like meditation, deep breathing, or yoga.
Prioritize Sleep: Aim for 7-9 hours of quality sleep per night. Address sleep disorders like sleep apnea.
Practice Good Oral Hygiene: Floss and brush regularly to control gum disease.
3. Medical Interventions
Depending on your overall risk, your doctor might recommend:
Statins: These cholesterol-lowering drugs also have a powerful anti-inflammatory effect and are proven to reduce hs-CRP levels and cardiovascular events.
Low-Dose Aspirin: For some high-risk individuals, this may be recommended (always under a doctor's supervision).
Summary
Elevated hs-CRP = Low-grade, chronic inflammation in the body.
Its most critical implication is an increased risk for heart attack and stroke.
It is a modifiable risk factor. Through significant lifestyle changes and, if necessary, medication, you can lower your hs-CRP and, more importantly, your overall health risk.
Disclaimer: This information is for educational purposes only. Always consult with your healthcare provider for a proper diagnosis and personalized treatment plan based on your specific health situation.
Core Components of Metabolic Dysfunction
The dysfunction typically involves problems in several key areas:
Insulin Resistance: This is the cornerstone. Your body's cells stop responding effectively to the hormone insulin. As a result, the pancreas pumps out more and more insulin to try to get glucose into the cells, leading to high insulin levels (hyperinsulinemia).
Dyslipidemia: An unhealthy pattern of blood lipids (fats), often characterized by:
High triglycerides
Low levels of HDL ("good") cholesterol
High levels of small, dense LDL ("bad") cholesterol particles
Central (Abdominal) Obesity: Excess fat stored around the organs in the abdomen (visceral fat) is highly metabolically active and releases inflammatory substances that drive insulin resistance.
Hypertension (High Blood Pressure): Often linked to insulin resistance and the associated changes in blood vessel function and kidney fluid handling.
Dysregulated Blood Sugar: This can range from mildly elevated fasting blood glucose to full-blown Type 2 Diabetes.
Chronic, Low-Grade Inflammation: The body is in a constant state of mild inflammation, driven by signals from excess visceral fat and other tissues.
Hepatic Steatosis (Non-Alcoholic Fatty Liver Disease - NAFLD): The buildup of fat in the liver, which is a direct consequence of the metabolic overload.
The Clinical Diagnosis: Metabolic Syndrome
When these dysfunctions cluster together in a specific way, it's often diagnosed as Metabolic Syndrome. While definitions vary slightly, a common one (from the International Diabetes Federation) requires central obesity plus two of the following:
Elevated triglycerides: ≥150 mg/dL (or on treatment)
Reduced HDL cholesterol: <40 mg/dL in men, <50 mg/dL in women (or on treatment)
Elevated blood pressure: Systolic ≥130 or Diastolic ≥85 mmHg (or on treatment)
Elevated fasting blood glucose: ≥100 mg/dL (or previously diagnosed Type 2 Diabetes)
Causes and Risk Factors
Metabolic dysfunction is a classic example of a condition arising from the interaction between genetics and lifestyle.
Primary Drivers (Lifestyle):
Diet: High intake of ultra-processed foods, sugary beverages, refined carbohydrates, and unhealthy fats.
Physical Inactivity: A sedentary lifestyle reduces the muscles' demand for glucose, worsening insulin resistance.
Chronic Stress: Leads to elevated cortisol, which promotes fat storage in the abdomen and increases blood sugar.
Inadequate Sleep: Disrupts hormones that regulate appetite (ghrelin and leptin) and increases insulin resistance.
Underlying Factors:
Genetics: A family history of Type 2 Diabetes or heart disease increases susceptibility.
Age: Risk increases with age.
Hormonal Changes: Conditions like PCOS (Polycystic Ovary Syndrome) are strongly linked to insulin resistance.
Consequences and Long-Term Risks
If left unaddressed, metabolic dysfunction significantly increases the risk for:
Cardiovascular Disease: Heart attack and stroke. This is the most significant risk.
Type 2 Diabetes: The progressive failure of the pancreas to overcome insulin resistance.
Non-Alcoholic Steatohepatitis (NASH) and Cirrhosis: The progression of fatty liver to inflammation and scarring.
Chronic Kidney Disease.
Certain Cancers: Such as breast, colon, and pancreatic cancer.
Neurodegenerative Diseases: Like Alzheimer's disease, sometimes referred to as "Type 3 Diabetes" due to its link to insulin resistance in the brain.
Management and Treatment
The good news is that metabolic dysfunction is largely preventable and reversible through comprehensive lifestyle changes. Medication may be used, but lifestyle is the foundation.
Dietary Changes:
Focus on Whole Foods: Prioritize vegetables, fruits, lean proteins, and healthy fats (like those in avocados, nuts, and olive oil).
Reduce Refined Carbs and Sugar: Cut out sugary drinks, white bread, pastries, and processed snacks.
Increase Fiber: From vegetables, legumes, and whole grains.
Physical Activity:
Aerobic Exercise: Aim for at least 150 minutes of moderate-intensity exercise (like brisk walking) per week.
Resistance Training: Building muscle mass (2-3 times per week) improves the body's ability to use glucose and improves insulin sensitivity.
Weight Management: Even a 5-10% reduction in body weight can dramatically improve insulin resistance, blood pressure, and lipid levels.
Stress Management and Sleep:
Practices like mindfulness, meditation, and ensuring 7-9 hours of quality sleep per night are crucial for regulating metabolic hormones.
Medications:
If lifestyle changes aren't enough, doctors may prescribe medications for specific issues:
Metformin: For improving insulin sensitivity.
Statins: For high cholesterol.
Blood Pressure medications.
In summary, metabolic dysfunction is a systemic problem rooted in modern lifestyle patterns. Addressing it requires a holistic approach that focuses on the underlying causes rather than just treating individual symptoms like high blood pressure or cholesterol in isolation.
当然可以。"代谢功能障碍"是一个广义术语,描述身体正常的代谢过程被扰乱,导致一系列负面健康影响的状态。它不是一个独立的疾病,而是一系列相互关联问题的总称。
您可以将新陈代谢想象成汽车的引擎。功能正常时,它能高效地将燃料(食物)转化为能量。代谢功能障碍就如同引擎开始运转不畅——它可能无法有效利用燃料、产生有害副产品,并最终损害其他系统。
代谢功能障碍的核心组成部分
这种功能障碍通常涉及以下几个关键方面的问题:
胰岛素抵抗: 这是问题的核心。身体细胞对激素胰岛素的反应不再有效。结果,胰腺会分泌更多的胰岛素,试图让葡萄糖进入细胞,导致高胰岛素血症。
血脂异常: 不健康的血脂模式,通常表现为:
高甘油三酯
低水平的高密度脂蛋白("好"胆固醇)
高水平的小而密低密度脂蛋白("坏"胆固醇)颗粒
中心性(腹部)肥胖: 储存在腹部器官周围的过多脂肪(内脏脂肪)具有高度代谢活性,会释放驱动胰岛素抵抗的炎症物质。
高血压: 通常与胰岛素抵抗以及相关的血管功能改变和肾脏液体处理功能变化有关。
血糖调节失常: 范围从轻度升高的空腹血糖到完全的2型糖尿病。
慢性、低度炎症: 身体处于一种持续的轻度炎症状态,由过多的内脏脂肪和其他组织发出的信号所驱动。
肝脂肪变性(非酒精性脂肪性肝病 - NAFLD): 肝脏中脂肪的堆积,这是代谢超负荷的直接后果。
临床诊断:代谢综合征
当这些功能障碍以特定方式聚集在一起时,通常被诊断为代谢综合征。虽然定义略有不同,但一个常见标准(来自国际糖尿病联盟)要求满足中心性肥胖加上以下两项:
甘油三酯升高: ≥ 150 mg/dL(或正在接受治疗)
高密度脂蛋白胆固醇降低: 男性 < 40 mg/dL,女性 < 50 mg/dL(或正在接受治疗)
血压升高: 收缩压 ≥ 130 或 舒张压 ≥ 85 mmHg(或正在接受治疗)
空腹血糖升高: ≥ 100 mg/dL(或已确诊为2型糖尿病)
病因和风险因素
代谢功能障碍是遗传和生活方式相互作用导致疾病的典型例子。
主要驱动因素(生活方式):
饮食: 高摄入超加工食品、含糖饮料、精制碳水化合物和不健康脂肪。
缺乏运动: 久坐的生活方式减少了肌肉对葡萄糖的需求,加剧了胰岛素抵抗。
慢性压力: 导致皮质醇水平升高,促进腹部脂肪储存并升高血糖。
睡眠不足: 扰乱调节食欲的激素(饥饿素和瘦素),并增加胰岛素抵抗。
潜在因素:
遗传: 有2型糖尿病或心脏病家族史的人易感性更高。
年龄: 风险随年龄增长而增加。
激素变化: 多囊卵巢综合征等疾病与胰岛素抵抗密切相关。
后果和长期风险
如果得不到解决,代谢功能障碍会显著增加以下风险:
心血管疾病: 心脏病发作和中风。这是最重要的风险。
2型糖尿病: 胰腺逐渐无法克服胰岛素抵抗。
非酒精性脂肪性肝炎和肝硬化: 脂肪肝发展为炎症和瘢痕。
慢性肾病。
某些癌症: 如乳腺癌、结肠癌和胰腺癌。
神经退行性疾病: 如阿尔茨海默病,由于其与大脑胰岛素抵抗的联系,有时被称为"3型糖尿病"。
管理和治疗
好消息是,代谢功能障碍在很大程度上可以通过全面的生活方式改变来预防和逆转。药物可能被使用,但生活方式是基础。
饮食改变:
专注于天然食物: 优先选择蔬菜、水果、瘦肉蛋白和健康脂肪(如牛油果、坚果和橄榄油中的脂肪)。
减少精制碳水和糖: 戒掉含糖饮料、白面包、糕点和加工零食。
增加纤维: 从蔬菜、豆类和全谷物中摄取。
体育锻炼:
有氧运动: 目标是每周至少150分钟的中等强度运动(如快走)。
阻力训练: 增加肌肉量(每周2-3次)可以提高身体利用葡萄糖的能力并改善胰岛素敏感性。
体重管理: 即使体重减少5-10%,也能显著改善胰岛素抵抗、血压和血脂水平。
压力管理和睡眠:
进行正念、冥想等练习,并保证每晚7-9小时的高质量睡眠,对于调节代谢激素至关重要。
药物:
如果生活方式改变不够,医生可能会针对具体问题开具药物:
二甲双胍: 用于改善胰岛素敏感性。
他汀类药物: 用于治疗高胆固醇。
降压药。
总结来说,代谢功能障碍是一个根植于现代生活模式的系统性问题。 解决它需要一个整体的方法,专注于根本原因,而不是仅仅孤立地治疗高血压或高胆固醇等个别症状。
如何預防和自我治療:
請做源頭處理:
參考:
高膽固醇就是有病嗎?
https://www.donnadreamhypnosis.com/2024/07/blog-post_20.html
打破對鷄蛋的誤解
港人患高膽固醇趨年輕化,如何自我療愈?
高膽固醇就是有病嗎?
https://www.donnadreamhypnosis.com/2024/07/blog-post_20.html
心臟病癌症中風與三高、糖尿病的關係
https://www.donnadreamhypnosis.com/2025/07/blog-post.html
小分子肽和輕草堂排毒對免疫系統自我攻擊的治療原理
https://www.donnadreamhypnosis.com/2025/03/blog-post_16.html
胰島素阻抗的症狀、原因和自我預防和療愈 ( 文章集)
https://www.donnadreamhypnosis.com/2025/09/blog-post_28.html
免疫系統的陰陽平衡
https://www.donnadreamhypnosis.com/2025/10/blog-post_15.html
我是如何幫助煙友戒煙減肥的?
https://www.donnadreamhypnosis.com/2025/06/blog-post_27.html
癌症治療後
https://www.donnadreamhypnosis.com/2025/06/blog-post_50.html
朋友和我分享白血病的治療
https://www.donnadreamhypnosis.com/2025/06/blog-post_73.html
業餘歌王白血病的治療和康復過程
https://www.donnadreamhypnosis.com/2025/04/blog-post_16.html
細胞與肽
https://www.donnadreamhypnosis.com/2025/08/blog-post_12.html
排毒拯救糖尿病
https://www.donnadreamhypnosis.com/2025/08/blog-post_24.html
《疾病的希望》工作坊總結
https://www.donnadreamhypnosis.com/2025/06/blog-post_26.html
排毒 - 疾病的預防和希望 (個案分享)
Kayson 老師工作坊 《爲什麽要排毒?》
連續血糖測試的結果分析與啓示
胰島素阻抗的嚴重後果
隱形殺手 - 胰島素阻抗
胰島素阻抗帶給我們多少問題
血糖控制正常,就不會有糖尿病并發症嗎?
沒有糖尿病,就不會胰島素阻抗?
血糖控制正常,就不會有糖尿病并發症嗎?不會有心臟病嗎?
糖尿病并發症、心臟病是否與血糖數據的關係成正比?
用生命換來的教訓:
心臟病與胰島素阻抗的關係
如何知道自己有心臟病風險?
爲什麽要排毒 ( 排毒療愈疾病的個案):
No comments:
Post a Comment